검색결과 : 6건
| No. | Article |
|---|---|
| 1 |
Intact and middle-down CIEF of commercial therapeutic monoclonal antibody products under non-denaturing conditions Schmailzl J, Vorage MW, Stutz H Electrophoresis, 41(12), 1109, 2020 |
| 2 |
Cleavage of the interchain disulfide bonds in rituximab increases its affinity for Fc gamma RIIIA Suzuki M, Yamanoi A, Machino Y, Kobayashi E, Fukuchi K, Tsukimoto M, Kojima S, Kohroki J, Akimoto K, Masuho Y Biochemical and Biophysical Research Communications, 436(3), 519, 2013 |
| 3 |
Imaging and measuring the rituximab-induced changes of mechanical properties in B-lymphoma cells using atomic force microscopy Li M, Liu LQ, Xi N, Wang YC, Dong ZL, Tabata O, Xiao XB, Zhang WJ Biochemical and Biophysical Research Communications, 404(2), 689, 2011 |
| 4 |
Anomalous expression of Thy1 (CD90) in B-cell lymphoma cells and proliferation inhibition by anti-Thy1 antibody treatment Ishiura Y, Kotani N, Yamashita R, Yamamoto H, Kozutsumi Y, Honke K Biochemical and Biophysical Research Communications, 396(2), 329, 2010 |
| 5 |
Escape mechanisms from antibody therapy to lymphoma cells: Downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation Sugimoto T, Tomita A, Hiraga J, Shimada K, Kiyoi H, Kinoshita T, Naoe T Biochemical and Biophysical Research Communications, 390(1), 48, 2009 |
| 6 |
Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO cells Kunert R, Steinfellner W, Purtscher M, Assadian A, Katinger H Biotechnology and Bioengineering, 67(1), 97, 2000 |